22 March, 2023
Management of Menopause
- Assessment of menopausal women should consider factors including patient’s age, symptoms and impact on quality of life, and risk for cardiovascular disease and osteoporosis
- In general, the benefits of hormone replacement therapy (HRT) outweigh the risks for most women with menopausal symptoms aged <60 years or within 10 years of menopause
- Transdermal oestrogen administration is associated with a lower risk of venous thromboembolism and stroke than oral administration
- Women should be informed that HRT is not a contraceptive method